Skip to main content

News

Annals of Long-Term Care
Long before patients receive a dementia diagnosis, many people begin to mismanage their finances as their memory, organizational skills, and self-control falter.
First Report Managed Care
Cumulative doses of phototherapy and related costs varied greatly among seven skin diseases, researchers highlighted in a new study.
Pharmacy Learning Network
More than 200,000 doses of the COVID-19 vaccine have gone to waste since December, and according to government data, two national pharmacy chains account for most of it.
First Report Managed Care
A new report from the Government Accountability Office casts doubt on whether insurers are abiding by federal law requiring parity in insurance coverage, which forbids health plans from passing along more of the bill for mental health care to patients than they would for medical or surgical care.
Pharmacy Learning Network
A female hormone used to reduce menopause symptoms in women is under a Class II recall.
Pharmacy Learning Network
A recall is active for a prescription steroid used to treat a variety of skin conditions, such as eczema, dermatitis, and allergies.
Pharmacy Learning Network
Sterility concerns due to defective containers have prompted Edge Pharma to voluntarily recall 5850 syringes of Betadine (povidone iodine) ophthalmic solution.
First Report Managed Care
A 35-year-old man with severe erythrodermic atopic dermatitis experienced clearance of his disease after 4 months of adding rescue tofacitinib to dupilumab therapy, according to a recent case report.
Annals of Long-Term Care
Responsible for 34% of the nation’s COVID-19 death toll, nursing homes and long-term care facilities get slammed by their investors and are often told to change.
Pharmacy Learning Network
A Class II recall is ongoing for a prescription medication used to treat a variety of fungal infections.
Back to Top